Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Liposomes Drug Delivery market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Liposomes Drug Deliverymarket, defines the market attractiveness level of Liposomes Drug Delivery market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Liposomes Drug Delivery industry, describes the types of Liposomes Drug Delivery market, the applications of major players and the market size, and deeply analyzes the current situation of the global Liposomes Drug Delivery market and the development prospects and opportunities of Liposomes Drug Delivery industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Liposomes Drug Delivery market in Chapter 13.
By Player:
Johnson & Johnson
Luye Pharma
Pacira
Teva Pharmaceutical
Sun Pharmaceutical
Ipsen (Onivyde)
CSPC
Sigma-Tau Group
Gilead Sciences
Fudan-Zhangjiang
Novartis
By Type:
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
By End-User:
Fungal Infection
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Liposomes Drug Delivery Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Liposomes Drug Delivery Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Liposomes Drug Delivery Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Liposomes Drug Delivery Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Liposomes Drug Delivery Market Analysis and Outlook to 2022
-
7.1 Global Liposomes Drug Delivery Consumption (2017-2022)
-
7.2 United States Liposomes Drug Delivery Consumption (2017-2022)
-
7.3 Europe Liposomes Drug Delivery Consumption (2017-2022)
-
7.4 China Liposomes Drug Delivery Consumption (2017-2022)
-
7.5 Japan Liposomes Drug Delivery Consumption (2017-2022)
-
7.6 India Liposomes Drug Delivery Consumption (2017-2022)
-
7.7 South Korea Liposomes Drug Delivery Consumption (2017-2022)
8 Region and Country-wise Liposomes Drug Delivery Market Analysis and Outlook to 2028
-
8.1 Global Liposomes Drug Delivery Consumption Forecast (2022-2028)
-
8.2 United States Liposomes Drug Delivery Consumption Forecast (2022-2028)
-
8.3 Europe Liposomes Drug Delivery Consumption Forecast (2022-2028)
-
8.4 China Liposomes Drug Delivery Consumption Forecast (2022-2028)
-
8.5 Japan Liposomes Drug Delivery Consumption Forecast (2022-2028)
-
8.6 India Liposomes Drug Delivery Consumption Forecast (2022-2028)
-
8.7 South Korea Liposomes Drug Delivery Consumption Forecast (2022-2028)
9 Global Liposomes Drug Delivery Market Outlook by Types and Applications to 2022
-
9.1 Global Liposomes Drug Delivery Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Liposomal Doxorubicin Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Liposomal Amphoteracin B Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Liposomal Paclitaxel Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Liposomes Drug Delivery Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Fungal Infection Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Other Consumption and Growth Rate (2017-2022)
10 Global Liposomes Drug Delivery Market Outlook by Types and Applications to 2028
-
10.1 Global Liposomes Drug Delivery Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Liposomal Doxorubicin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Liposomal Amphoteracin B Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Liposomal Paclitaxel Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Liposomes Drug Delivery Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Fungal Infection Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Liposomes Drug Delivery Import and Export Analysis (Top 5 Countries)
-
11.1 Global Liposomes Drug Delivery Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Liposomes Drug Delivery Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Liposomes Drug Delivery Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Liposomes Drug Delivery Market Competitive Analysis
-
14.1 Johnson & Johnson
-
14.1.1 Johnson & Johnson Company Details
-
14.1.2 Johnson & Johnson Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson & Johnson Liposomes Drug Delivery Product and Service
-
14.2 Luye Pharma
-
14.2.1 Luye Pharma Company Details
-
14.2.2 Luye Pharma Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Luye Pharma Liposomes Drug Delivery Product and Service
-
14.3 Pacira
-
14.3.1 Pacira Company Details
-
14.3.2 Pacira Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pacira Liposomes Drug Delivery Product and Service
-
14.4 Teva Pharmaceutical
-
14.4.1 Teva Pharmaceutical Company Details
-
14.4.2 Teva Pharmaceutical Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Teva Pharmaceutical Liposomes Drug Delivery Product and Service
-
14.5 Sun Pharmaceutical
-
14.5.1 Sun Pharmaceutical Company Details
-
14.5.2 Sun Pharmaceutical Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sun Pharmaceutical Liposomes Drug Delivery Product and Service
-
14.6 Ipsen (Onivyde)
-
14.6.1 Ipsen (Onivyde) Company Details
-
14.6.2 Ipsen (Onivyde) Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Ipsen (Onivyde) Liposomes Drug Delivery Product and Service
-
14.7 CSPC
-
14.7.1 CSPC Company Details
-
14.7.2 CSPC Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 CSPC Liposomes Drug Delivery Product and Service
-
14.8 Sigma-Tau Group
-
14.8.1 Sigma-Tau Group Company Details
-
14.8.2 Sigma-Tau Group Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sigma-Tau Group Liposomes Drug Delivery Product and Service
-
14.9 Gilead Sciences
-
14.9.1 Gilead Sciences Company Details
-
14.9.2 Gilead Sciences Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Gilead Sciences Liposomes Drug Delivery Product and Service
-
14.10 Fudan-Zhangjiang
-
14.10.1 Fudan-Zhangjiang Company Details
-
14.10.2 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Fudan-Zhangjiang Liposomes Drug Delivery Product and Service
-
14.11 Novartis
-
14.11.1 Novartis Company Details
-
14.11.2 Novartis Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Novartis Liposomes Drug Delivery Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Liposomes Drug Delivery
-
Figure Liposomes Drug Delivery Picture
-
Table Global Liposomes Drug Delivery Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Liposomes Drug Delivery Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Liposomes Drug Delivery Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Liposomes Drug Delivery Consumption by Country (2017-2022)
-
Figure United States Liposomes Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table Europe Liposomes Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure China Liposomes Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Japan Liposomes Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure India Liposomes Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure South Korea Liposomes Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Global Liposomes Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure United States Liposomes Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Liposomes Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Liposomes Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Liposomes Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Liposomes Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Liposomes Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liposomal Doxorubicin Consumption and Growth Rate (2017-2022)
-
Figure Global Liposomal Amphoteracin B Consumption and Growth Rate (2017-2022)
-
Figure Global Liposomal Paclitaxel Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Fungal Infection Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Liposomal Doxorubicin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liposomal Amphoteracin B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liposomal Paclitaxel Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fungal Infection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Liposomes Drug Delivery Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Liposomes Drug Delivery Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Liposomes Drug Delivery Product and Service
-
Table Luye Pharma (Foundation Year, Company Profile and etc.)
-
Table Luye Pharma Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Luye Pharma Liposomes Drug Delivery Product and Service
-
Table Pacira (Foundation Year, Company Profile and etc.)
-
Table Pacira Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pacira Liposomes Drug Delivery Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Liposomes Drug Delivery Product and Service
-
Table Sun Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceutical Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Liposomes Drug Delivery Product and Service
-
Table Ipsen (Onivyde) (Foundation Year, Company Profile and etc.)
-
Table Ipsen (Onivyde) Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ipsen (Onivyde) Liposomes Drug Delivery Product and Service
-
Table CSPC (Foundation Year, Company Profile and etc.)
-
Table CSPC Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSPC Liposomes Drug Delivery Product and Service
-
Table Sigma-Tau Group (Foundation Year, Company Profile and etc.)
-
Table Sigma-Tau Group Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sigma-Tau Group Liposomes Drug Delivery Product and Service
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Liposomes Drug Delivery Product and Service
-
Table Fudan-Zhangjiang (Foundation Year, Company Profile and etc.)
-
Table Fudan-Zhangjiang Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fudan-Zhangjiang Liposomes Drug Delivery Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Liposomes Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Liposomes Drug Delivery Product and Service
-
